Status
Conditions
About
To evaluate the dynamic alterations of Th2/Th1 for the prediction of clinical immunity and how it was related to 28 day-prognosis and ICU-acquired infections among critically ill patients of community-acquired severe sepsis with new onset.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
For community-acquired severe sepsis group:
Inclusion Criteria:
Exclusion Criteria:
For non-severe sepsis ICU control group:
Inclusion Criteria:
Exclusion Criteria:
For healthy control group:
Inclusion Criteria:
Exclusion Criteria:
85 participants in 3 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal